Scorpion sting study tests simpler antivenom dosing
NCT ID NCT06333834
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two different ways of giving scorpion antivenom to adults who were stung. One group got a dose based on how severe their symptoms were, while the other group got the same dose for everyone. The goal was to see if the simpler approach works just as well at relieving symptoms. The trial involved 56 people and looked at how fast symptoms went away, side effects, and how much venom and antivenom was in the blood.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- scorpion antivenom
- What this could lead to
- If successful, this could show that a simpler, one-size-fits-all dose of antivenom works just as well as the current severity-based dosing, making treatment faster and easier.
- What could go wrong
- This is a small, completed Phase 2/3 trial with only 56 participants, so results may not apply broadly. The experimental dose may not be as effective in more severe cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2/3
Runs two stages together: whether the treatment works, then large-scale confirmation.
- Participants
-
56 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Individuals aged 18 or older presenting with a diagnosis of scorpionism to the emergency department. * Treated solely with paracetamol, scorpion antivenom, saline solution, and local ice application. * Any gender. * Less than two hours elapsed since scorpion sting. * Willing to participate in the study through written informed consent. Exclusion Criteria: * Allergies or contraindications to any of the study medications. * Uncertainty regarding scorpion sting. * Previous treatment by another physician. * Intramuscular administration of scorpion antivenom due to urgent clinical conditions. * Decision not to provide informed consent. * Any limitations hindering the proper understanding of study participation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Centruroides envenomation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Servicios Médicos Municipales de San Pedro Tlaquepaque.
Tlaquepaque, Jalisco, 45560, Mexico